Food blenders & mixers market was valued at $6.2 billion in 2025 and is projected to reach $10.7 billion by 2035, growing at a CAGR of 5.6% during the forecast period (2026-2035). The global food blenders & mixers market is witnessing gradual technological transformation with the integration of digital and connected features in household appliances. Modern smart blenders incorporate Internet-of-Things (IoT) functionality, allowing users to operate and monitor blending programs through dedicated mobile applications. These appliances often include voice-control compatibility with smart home systems, enabling hands-free operation and integration within connected kitchen environments. Additionally, automatic blending presets and guided recipe functions support improved precision and consistency in food preparation. Such features provide benefits including remote operation, customizable blending modes, and the potential for nutrition tracking through companion applications.

DNA gyrase subunit B (EC 5.99.1.3) market was valued at $1.6 billion in 2025 and is projected to reach $3.6 billion by 2035, growing at a CAGR of 8.8% during the forecast period (2026-2035). The increasing prevalence of antimicrobial resistance is a primary factor supporting the growth of the DNA gyrase subunit B market. According to the Centers for Disease Control and Prevention, more than 2.8 million antimicrobial-resistant infections occur annually in the United States, resulting in over 35,000 deaths, reflecting the significant clinical burden associated with resistant pathogens. In parallel, the World Health Organization reported that at least 1.27 million deaths were directly attributed to antimicrobial resistance, with nearly 5 million deaths associated with such infections globally. The continued rise in resistance across key pathogens, including Klebsiella pneumoniae and other gram-negative bacteria, is limiting the effectiveness of existing antibiotic classes. This has created a clear therapeutic gap, increasing the need for drugs with novel mechanisms of action such as DNA gyrase subunit B inhibitors.

Diclofenac market was valued at $4.2 billion in 2025 and is projected to reach $6.7 billion by 2035, growing at a CAGR of 4.8% during the forecast period (2026-2035). The diclofenac market is experiencing steady growth in emerging economies, particularly in countries such as India, where musculoskeletal disorders account for nearly 20–30% of outpatient cases in urban healthcare settings. Improved healthcare access and expansion of generic drug availability have led to a measurable increase in prescription volumes across both public and private sectors. For instance, diclofenac-based formulations remain among the top prescribed NSAIDs for osteoarthritis and post-operative pain management in several regional hospitals.

Diagnostic Enzymes market was valued at $4.8 billion in 2025 and is projected to reach $9.5 billion by 2035, growing at a CAGR of 7.2% during the forecast period (2026-2035). The global diagnostic enzymes market is experiencing significant growth driven by the rapid expansion of diagnostic laboratory infrastructure in emerging economies such as India, China, and Brazil. India alone had over 24,000 diagnostic laboratories in 2023, with the number continuing to rise, reflecting increasing demand for enzyme-based reagents in molecular and clinical diagnostics. Modern laboratories are increasingly offering molecular testing for infectious diseases, cancer markers, and genetic disorders, necessitating high?performance enzymes such as polymerases, reverse transcriptases, and nucleases.

Dermatological Drugs market was valued at $41.5 billion in 2025 and is projected to reach $91.4 billion by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035). The global dermatological drugs market is witnessing a significant shift toward biologics and targeted immunotherapies, which have emerged as the dominant drivers of innovation, particularly in the treatment of chronic conditions such as psoriasis, atopic dermatitis, and other autoimmune skin disorders. These advanced therapies, primarily based on monoclonal antibodies and selective cytokine inhibitors, are redefining treatment paradigms by specifically targeting key inflammatory pathways, including interleukin (IL)-17, IL-23, and Janus kinase (JAK) signaling.  For instance, in September 2025, Johnson & Johnson received regulatory approval to extend the use of Tremfya for pediatric patients with moderate-to-severe plaque psoriasis. This development reflects the broader shift toward highly selective cytokine inhibition, particularly IL-23 targeting, which has demonstrated strong efficacy and long-term disease control in dermatological conditions.

Dendritic Cell Cancer Vaccine market was valued at $600.5 million in 2025 and is projected to reach $1,760.6 million by 2035, growing at a CAGR of 11.4% during the forecast period (2026-2035).The rising global burden of cancer is a fundamental driver for the growth of the dendritic cell cancer vaccine market. Increasing cancer prevalence directly expands the addressable patient pool, thereby accelerating demand for advanced and targeted treatment approaches. Epidemiological trends indicate a continuous surge in cancer diagnoses across major regions, reinforcing the need for innovative therapies. For instance, China reports nearly 5 million new cancer cases annually, accounting for approximately one-quarter of global diagnoses, with oncology representing a significant share of its research and development pipeline. Similarly, the United States recorded over 2 million new cancer cases in 2024, averaging around 5,480 diagnoses per day, highlighting the scale of unmet clinical demand.

Compressor control system market was valued at $7.3 billion in 2025 and is projected to reach $13.3 billion by 2035, growing at a CAGR of 6.3% during the forecast period (2026-2035). The global compressor control system market is undergoing a significant transformation driven by digitalization and connectivity. Increasingly, manufacturers are incorporating IoT?enabled sensors and IIoT devices into new compressor systems, enabling real-time performance monitoring and condition-based analytics. Industry estimates indicate that over 29% of newly deployed systems in 2024 feature IoT connectivity, facilitating remote diagnostics and predictive maintenance. This shift is empowering operators to proactively identify issues, optimize performance, and extend equipment lifespan. Cloud-based monitoring and remote control solutions are further accelerating market adoption by allowing centralized supervision of compressor assets across multiple sites.

Compound Feed market was valued at $280.5 billion in 2025 and is projected to reach $466.4 billion by 2035, growing at a CAGR of 5.3% during the forecast period (2026-2035). The global compound feed market is witnessing a significant shift toward health-oriented feed solutions in response to increasing disease risks across livestock and aquaculture sectors. Advanced aquafeeds are now being formulated with functional ingredients such as probiotics, prebiotics, antioxidants, vitamins, and minerals, aimed at enhancing the immune systems of aquatic species. Unlike conventional feeds that primarily focus on growth performance, these innovative formulations are designed to improve disease resistance and reduce susceptibility to bacterial and viral infections. This trend reflects a growing emphasis on sustainable and resilient animal production, where preventive nutrition plays a central role in maintaining animal health. Leading industry participants, including Cargill, Archer Daniels Midland, BioMar and Alltech, are actively investing in research and development to expand their portfolios of functional feed solutions.

Collision avoidance sensors market was valued at $11.4 billion in 2025 and is projected to reach $36.6 billion by 2035, growing at a CAGR of 12.4% during the forecast period (2026-2035). Collision avoidance sensors are increasingly critical in aerospace and defence operations, driven by rising platform density and complex mission environments. Technological innovation in radar systems is strengthening detection accuracy and operational reliability, thereby supporting market expansion. Major technological advancement such development of 4D imaging radar, which measures range, azimuth, elevation, and velocity (Doppler) simultaneously for enhanced object tracking. The integration of Doppler data with three dimensional spatial mapping improves target discrimination and situational awareness in dynamic environments. Defense aerospace firms are increasingly developing modular, rapidly deployable mission systems that enhance aircraft versatility without requiring permanent structural modifications. These adaptable solutions are designed to expand intelligence, surveillance, and reconnaissance capabilities while offering flexible multi-role functionality across diverse operational environments. 

Cancer supportive care drugs market was valued at $13.8 billion in 2025 and is projected to reach $17.8 billion by 2035, growing at a CAGR of 2.6% during the forecast period (2026-2035). The global cancer supportive care drugs market is experiencing significant growth, driven by the rising prevalence of cancer and the increasing need to manage treatment-related side effects effectively. Supportive care therapies, including granulocyte colony-stimulating factors, erythropoiesis-stimulating agents, antiemetics, bisphosphonates, opioids, and NSAIDs, are playing a crucial role in improving patient outcomes and maintaining adherence to therapy. In 2024, the US recorded over 2 million new cancer cases, averaging approximately 5,480 diagnoses per day, while the UK has nearly 3.5 million individuals living with cancer and more than 420,000 new cases annually.